ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Asston Pharmaceuticals Ltd submitted its quarterly shareholding pattern disclosure, detailing the shareholding status of promoters and public shareholders for the period ended March 2026.
Asston Pharmaceuticals Limited (BSE: 544445) declared the non-applicability of the Annual Secretarial Compliance Report under SEBI (LODR) Regulation 15(2). As an SME-listed entity, the company is exempt from certain corporate governance provisions. The company confirms it will continue to comply with all other applicable listing regulations.